Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo

PLoS Pathogens

Volumn 2, Issue 7, 2006, Pages 0636-0649

  Nobile, Clarissa J ^a   Andes, David R ^b   Nett, Jeniel E ^b   Smith Jr , Frank J ^a   Yue, Fu ^c   Phan, Quynh Trang ^c   Edwards Jr , John E ^c,d   Filler, Scott G ^c,d   Mitchell, Aaron P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; MEMBRANE PROTEIN; MUTANT PROTEIN; PROTEIN BCR1; PROTEIN ECE1; PROTEIN HWP1; UNCLASSIFIED DRUG; ALA1 PROTEIN, CANDIDA ALBICANS; ALS1 PROTEIN, CANDIDA ALBICANS; ALS3 PROTEIN, CANDIDA ALBICANS; BREAKPOINT CLUSTER REGION PROTEIN; CELL ADHESION MOLECULE; ECE1 PROTEIN, CANDIDA ALBICANS; FUNGAL PROTEIN; HWP1 PROTEIN, CANDIDA ALBICANS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOFILM; CANDIDA ALBICANS; CATHETER INFECTION; CONTROLLED STUDY; FUNGAL STRAIN; GENE OVEREXPRESSION; GENE TARGETING; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; ANIMAL; BAGG ALBINO MOUSE; CANDIDIASIS; CATHETERIZATION; CELL ADHESION; FUNGAL GENE; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MUTATION; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

CANDIDA ALBICANS;

ANIMALS; BIOFILMS; CANDIDA ALBICANS; CANDIDIASIS; CATHETERIZATION; CELL ADHESION; CELL ADHESION MOLECULES; FUNGAL PROTEINS; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MUTATION; PROTO-ONCOGENE PROTEINS C-BCR; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33746636085     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.0020063     Document Type: Article

References (45)

1. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30-36.
2. Fux CA, Costerton JW, Stewart PS, Stoodley P (2005) Survival strategies of infectious biofilms. Trends Microbiol 13: 34-40.
3. Kumamoto CA (2002) Candida biofilms. Curr Opin Microbiol 5: 608-611.
4. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL (2005) Candida biofilms: An update. Eukaryot Cell 4: 633-638.
5. Kojic EM, Darouiche RO (2004) Candida infections of medical devices. Clin Microbiol Rev 17: 255-267.
6. von Eiff C, Jansen B, Kohnen W, Becker K (2005) Infections associated with medical devices: Pathogenesis, management and prophylaxis. Drugs 65: 179-214.
7. Bertagnolio S, de Gaetano Donati K, Tacconelli E, Scoppettuolo G, Posteraro B, et al. (2004) Hospital-acquired candidemia in HIV-infected patients. Incidence, risk factors and predictors of outcome. J Chemother 16: 172-178.
8. Beck-Sague C, Jarvis WR (1993) Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J Infect Dis 167: 1247-1251.
9. Maki DG, Tambyah PA (2001) Engineering out the risk for infection with urinary catheters. Emerg Infect Dis 7: 342-347.
10. Chandra J, Patel JD, Li J, Zhou G, Mukherjee PK, et al. (2005) Modification of surface properties of biomaterials influences the ability of Candida albicans to form biofilms. Appl Environ Microbiol 71: 8795-8801.
11. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA (2002) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70: 878-888.
12. Baillie GS, Douglas LJ (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46: 397-403.
13. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, et al. (2001) Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. J Bacteriol 183: 5385-5394.
14. Nobile CJ, Mitchell AP (2005) Regulation of cell-surface genes and biofilm formation by the C. albicans transcription factor Bcr1p. Curr Biol 15: 1150-1155.
15. Richard ML, Nobile CJ, Bruno VM, Mitchell AP (2005) Candida albicans biofilm-defective mutants. Eukaryot Cell 4: 1493-1502.
16. Chagneau C, Saier MH Jr (2004) Biofilm-defective mutants of Bacillus subtilis. J Mol Microbiol Biotechnol 8: 177-188.
17. Schinabeck MK, Long LA, Hossain MA, Chandra J, Mukherjee PK, et al. (2004) Rabbit model of Candida albicans biofilm infection: Liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 48: 1727-1732.
18. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, et al. (2004) Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72: 6023-6031.
19. Schweizer A, Rupp S, Taylor BN, Rollinghoff M, Schroppel K (2000) The TEA/ATTS transcription factor CaTec1p regulates hyphal development and virulence in Candida albicans. Mol Microbiol 38: 435-445.
20. Sopko R, Huang D, Preston N, Chua G, Papp B, et al. (2006) Mapping pathways and phenotypes by systematic gene overexpression. Mol Cell 21: 319-330.
21. Braun BR, Johnson AD (2000) TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155: 57-67.
22. Liu TT, Lee RE, Barker KS, Lee RE, Wei L, et al. (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49: 2226-2236.
23. Weissman Z, Kornitzer D (2004) A family of Candida cell surface haem-binding proteins involved in haemin and haemoglobin-iron utilization. Mol Microbiol 53: 1209-1220.
24. McCreath KJ, Specht CA, Robbins PW (1995) Molecular cloning and characterization of chitinase genes from Candida albicans. Proc Natl Acad Sci U S A 92: 2544-2548.
25. Cao YY, Cao YB, Xu Z, Ying K, Li Y, et al. (2005) cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol. Antimicrob Agents Chemother 49: 584-589.
26. Bensen ES, Martin SJ, Li M, Berman J, Davis DA (2004) Transcriptional profiling in Candida albicans reveals new adaptive responses to extracellular pH and functions for Rim101p. Mol Microbiol 54: 1335-1351.
27. Hoyer LL (2001) The ALS gene family of Candida albicans. Trends Microbiol 9: 176-180.
28. Sundstrom P (2002) Adhesion in Candida spp. Cell Microbiol 4: 461-469.
29. Sheppard DC, Yeaman MR, Welch WH, Phan QT, Fu Y, et al. (2004) Functional and structural diversity in the Als protein family of Candida albicans. J Biol Chem 279: 30480-30489.
30. Zhao X, Oh SH, Yeater KM, Hoyer LL (2005) Analysis of the Candida albicans Als2p and Als4p adhesins suggests the potential for compensatory function within the Als family. Microbiology 151: 1619-1630.
31. Staab JF, Bradway SD, Fidel PL, Sundstrom P (1999) Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283: 1535-1538.
32. Zhao R, Daniels KJ, Lockhart SR, Yeater KM, Hoyer LL, et al. (2005) Unique aspects of gene expression during Candida albicans mating and possible G(1) dependency. Eukaryot Cell 4: 1175-1190.
33. Bennett RJ, Uhl MA, Miller MG, Johnson AD (2003) Identification and characterization of a Candida albicans mating pheromone. Mol Cell Biol 23: 8189-8201.
34. Fonzi WA, Irwin MY (1993) Isogenic strain construction and gene mapping in Candida albicans. Genetics 134: 717-728.
35. Birse CE, Irwin MY, Fonzi WA, Sypherd PS (1993) Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect Immun 61: 3648-3655.
36. Liu H, Kohler J, Fink GR (1994) Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science 266: 1723-1726.
37. Wilson RB, Davis D, Mitchell AP (1999) Rapid hypothesis testing with Candida albicans through gene disruption with short homology regions. J Bacteriol 181: 1868-1874.
38. Sanchez AA, Johnston DA, Myers C, Edwards JE Jr, Mitchell AP, et al. (2004) Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro. Infect Immun 72: 598-601.
39. Fu Y, Ibrahim AS, Sheppard DC, Chen YC, French SW, et al. (2002) Candida albicans Als1p: An adhesin that is a downstream effector of the EFG1 filamentation pathway. Mol Microbiol 44: 61-72.
40. Davis DA, Bruno VM, Loza L, Filler SG, Mitchell AP (2002) Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 162: 1573-1581.
41. Spreghini E, Davis DA, Subaran R, Kim M, Mitchell AP (2003) Roles of Candida albicans Dfg5p and Dcw1p cell surface proteins in growth and hypha formation. Eukaryot Cell 2: 746-755.
42. Shen J, Guo W, Kohler JR (2005) CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species. Infect Immun 73: 1239-1242.
43. Davis D, Wilson RB, Mitchell AP (2000) RIM101-dependent and-independent pathways govern pH responses in Candida albicans. Mol Cell Biol 20: 971-978.
44. Park H, Myers CL, Sheppard DC, Phan QT, Sanchez AA, et al. (2005) Role of the fungal Ras-protein kinase A pathway in governing epithelial cell interactions during oropharyngeal candidiasis. Cell Microbiol 7: 499-510.
45. Green CB, Cheng G, Chandra J, Mukherjee P, Ghannoum MA, et al. (2004) RT-PCR detection of Candida albicans ALS gene expression in the reconstituted human epithelium (RHE) model of oral candidiasis and in model biofilms. Microbiology 150: 267-275.